US Patent Issued to PAMGENE, Leiden University Medical Centre on Feb. 10 for "Method for predicting the response of melanoma patients to a medicament" (Dutch Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,946, issued on Feb. 10, was assigned to PAMGENE BV ('s-Hertogenbosch, Netherlands) and Leiden University Medical Centre (Leiden, Netherlands).

"Method for predicting the response of melanoma patients to a medicament" was invented by Robby Ruijtenbeek (Utrecht, Netherlands), Liesbeth Coosje Hovestad-Bijl ('s-Hertogenbosch, Netherlands), Richard De Wijn (Nijmegen, Netherlands), Sjoerd H. Van Der Burg (Waddinxveen, Netherlands) and Elizabeth M. E. Verdegaal (Sassenheim, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for determining or predicting the response of a patient diagnosed with melanoma to t...